• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性转甲状腺素淀粉样变性患者源性转甲状腺素蛋白衍生淀粉样纤维的冷冻电镜结构。

Cryo-EM structure of a transthyretin-derived amyloid fibril from a patient with hereditary ATTR amyloidosis.

机构信息

Institute of Protein Biochemistry, Ulm University, 89081, Ulm, Germany.

Core Unit Mass Spectrometry and Proteomics, Ulm University, 89081, Ulm, Germany.

出版信息

Nat Commun. 2019 Nov 1;10(1):5008. doi: 10.1038/s41467-019-13038-z.

DOI:10.1038/s41467-019-13038-z
PMID:31676763
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6825171/
Abstract

ATTR amyloidosis is one of the worldwide most abundant forms of systemic amyloidosis. The disease is caused by the misfolding of transthyretin protein and the formation of amyloid deposits at different sites within the body. Here, we present a 2.97 Å cryo electron microscopy structure of a fibril purified from the tissue of a patient with hereditary Val30Met ATTR amyloidosis. The fibril consists of a single protofilament that is formed from an N-terminal and a C-terminal fragment of transthyretin. Our structure provides insights into the mechanism of misfolding and implies the formation of an early fibril state from unfolded transthyretin molecules, which upon proteolysis converts into mature ATTR amyloid fibrils.

摘要

ATTR 淀粉样变性是全球最常见的系统性淀粉样变性之一。该疾病是由转甲状腺素蛋白的错误折叠和在体内不同部位形成淀粉样沉积物引起的。在这里,我们展示了从遗传性 Val30Met ATTR 淀粉样变性患者组织中纯化的纤维的 2.97 Å 冷冻电子显微镜结构。该纤维由转甲状腺素蛋白的 N 端和 C 端片段组成的单个原纤维组成。我们的结构提供了对错误折叠机制的深入了解,并暗示了未折叠转甲状腺素蛋白分子形成早期纤维状态,随后在蛋白酶解作用下转化为成熟的 ATTR 淀粉样纤维。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/167e/6825171/81ff4086fb4d/41467_2019_13038_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/167e/6825171/cf5464fdfc06/41467_2019_13038_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/167e/6825171/b1677ba06607/41467_2019_13038_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/167e/6825171/87383efe2906/41467_2019_13038_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/167e/6825171/791ccac06c90/41467_2019_13038_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/167e/6825171/53e0c4f73e47/41467_2019_13038_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/167e/6825171/81ff4086fb4d/41467_2019_13038_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/167e/6825171/cf5464fdfc06/41467_2019_13038_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/167e/6825171/b1677ba06607/41467_2019_13038_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/167e/6825171/87383efe2906/41467_2019_13038_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/167e/6825171/791ccac06c90/41467_2019_13038_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/167e/6825171/53e0c4f73e47/41467_2019_13038_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/167e/6825171/81ff4086fb4d/41467_2019_13038_Fig6_HTML.jpg

相似文献

1
Cryo-EM structure of a transthyretin-derived amyloid fibril from a patient with hereditary ATTR amyloidosis.遗传性转甲状腺素淀粉样变性患者源性转甲状腺素蛋白衍生淀粉样纤维的冷冻电镜结构。
Nat Commun. 2019 Nov 1;10(1):5008. doi: 10.1038/s41467-019-13038-z.
2
Common transthyretin-derived amyloid fibril structures in patients with hereditary ATTR amyloidosis.遗传性转甲状腺素淀粉样变性患者常见的转甲状腺素衍生的淀粉样纤维结构。
Nat Commun. 2023 Nov 22;14(1):7623. doi: 10.1038/s41467-023-43301-3.
3
Structural basis for transthyretin amyloid formation in vitreous body of the eye.眼玻璃体中原甲状腺素蛋白淀粉样形成的结构基础。
Nat Commun. 2021 Dec 8;12(1):7141. doi: 10.1038/s41467-021-27481-4.
4
Cryo-EM structure of an ATTRwt amyloid fibril from systemic non-hereditary transthyretin amyloidosis.系统性非遗传性转甲状腺素蛋白淀粉样变性的野生型 ATTR 淀粉样纤维的冷冻电镜结构。
Nat Commun. 2022 Oct 27;13(1):6398. doi: 10.1038/s41467-022-33591-4.
5
Methods to study the structure of misfolded protein states in systemic amyloidosis.研究系统性淀粉样变性中错误折叠蛋白状态结构的方法。
Biochem Soc Trans. 2021 Apr 30;49(2):977-985. doi: 10.1042/BST20201022.
6
Amyloid seeding of transthyretin by ex vivo cardiac fibrils and its inhibition.转甲状腺素蛋白心脏纤维丝的体外淀粉样纤维形成及其抑制。
Proc Natl Acad Sci U S A. 2018 Jul 17;115(29):E6741-E6750. doi: 10.1073/pnas.1805131115. Epub 2018 Jun 28.
7
A cell-based high-throughput screening method to directly examine transthyretin amyloid fibril formation at neutral pH.一种基于细胞的高通量筛选方法,可直接在中性 pH 条件下检测转甲状腺素蛋白淀粉样纤维的形成。
J Biol Chem. 2019 Jul 19;294(29):11259-11275. doi: 10.1074/jbc.RA119.007851. Epub 2019 Jun 5.
8
Amyloid fibril composition within hereditary Val30Met (p. Val50Met) transthyretin amyloidosis families.遗传性 Val30Met(p.Val50Met)转甲状腺素蛋白淀粉样变性家族中的淀粉样纤维组成。
PLoS One. 2019 Feb 27;14(2):e0211983. doi: 10.1371/journal.pone.0211983. eCollection 2019.
9
Cryo-EM confirms a common fibril fold in the heart of four patients with ATTRwt amyloidosis.冷冻电镜确认了 4 位转甲状腺素蛋白野生型淀粉样变心肌病患者心脏中的一种常见纤维折叠。
Commun Biol. 2024 Jul 27;7(1):905. doi: 10.1038/s42003-024-06588-6.
10
One mutation, two distinct disease variants: unravelling the impact of transthyretin amyloid fibril composition.一种突变,两种不同的疾病变异体:解析转甲状腺素蛋白淀粉样纤维组成的影响。
J Intern Med. 2017 Apr;281(4):337-347. doi: 10.1111/joim.12585. Epub 2017 Jan 17.

引用本文的文献

1
A Shared Amyloid Architecture in Cardiac Fibrils from Three Neuropathy-Associated ATTR Variants.三种与神经病变相关的ATTR变体的心脏原纤维中共享的淀粉样蛋白结构
bioRxiv. 2025 Aug 7:2025.08.05.667944. doi: 10.1101/2025.08.05.667944.
2
Development of a rapid and novel diagnostic technique for cardiac amyloidosis using Raman spectroscopy.利用拉曼光谱技术开发一种快速且新颖的心脏淀粉样变性诊断技术。
Res Sq. 2025 Jun 25:rs.3.rs-6795517. doi: 10.21203/rs.3.rs-6795517/v1.
3
Cryo-EM of wild-type and mutant PMEL amyloid cores reveals structural mechanism of pigment dispersion syndrome.

本文引用的文献

1
Morphological and primary structural consistency of fibrils from different AA patients (common variant).不同 AA 患者(常见变异型)的纤维的形态和初级结构一致性。
Amyloid. 2019 Sep;26(3):164-170. doi: 10.1080/13506129.2019.1628015. Epub 2019 Jun 26.
2
Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease.遗传性转甲状腺素蛋白淀粉样变性病:致命疾病的医学进步典范。
Nat Rev Neurol. 2019 Jul;15(7):387-404. doi: 10.1038/s41582-019-0210-4. Epub 2019 Jun 17.
3
Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review.
野生型和突变型PMEL淀粉样蛋白核心的冷冻电镜揭示色素分散综合征的结构机制。
Nat Commun. 2025 Jul 1;16(1):5411. doi: 10.1038/s41467-025-61233-y.
4
Three scenarios for amyloid transformation in the context of the funnel model.在漏斗模型背景下淀粉样蛋白转化的三种情形。
Comput Struct Biotechnol J. 2025 Apr 13;27:1648-1659. doi: 10.1016/j.csbj.2025.04.016. eCollection 2025.
5
Hereditary Transthyretin Cardiac Amyloidosis With the p.V142I Variant: Mechanistic Insights and Diagnostic Challenges.携带p.V142I变异的遗传性转甲状腺素蛋白心脏淀粉样变性:机制见解与诊断挑战
Circ Heart Fail. 2025 Jun;18(6):e012469. doi: 10.1161/CIRCHEARTFAILURE.124.012469. Epub 2025 Mar 14.
6
Initiation of transthyretin aggregation at neutral pH by fluid agitation.通过液体搅拌在中性pH条件下引发转甲状腺素蛋白聚集。
Proc Natl Acad Sci U S A. 2025 Mar 18;122(11):e2425230122. doi: 10.1073/pnas.2425230122. Epub 2025 Mar 11.
7
Mass Spectrometry-Based Protein Footprinting for Protein Structure Characterization.基于质谱的蛋白质足迹分析用于蛋白质结构表征
Acc Chem Res. 2025 Jan 21;58(2):165-176. doi: 10.1021/acs.accounts.4c00545. Epub 2025 Jan 5.
8
Misfolding of transthyretin in vivo is controlled by the redox environment and macromolecular crowding.体内转甲状腺素蛋白的错误折叠受氧化还原环境和大分子拥挤效应的控制。
J Biol Chem. 2025 Jan;301(1):108031. doi: 10.1016/j.jbc.2024.108031. Epub 2024 Nov 28.
9
Aggregation of Transthyretin by Fluid Agitation.通过液体搅拌使转甲状腺素蛋白聚集。
bioRxiv. 2024 Nov 11:2024.11.08.622726. doi: 10.1101/2024.11.08.622726.
10
ATTRv-V30M amyloid fibrils from heart and nerves exhibit structural homogeneity.来自心脏和神经的ATTRv-V30M淀粉样原纤维表现出结构同质性。
Structure. 2024 Dec 5;32(12):2244-2250.e3. doi: 10.1016/j.str.2024.09.021. Epub 2024 Oct 17.
转甲状腺素蛋白淀粉样心肌病:美国心脏病学会最新临床综述
J Am Coll Cardiol. 2019 Jun 11;73(22):2872-2891. doi: 10.1016/j.jacc.2019.04.003.
4
Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules.慢性创伤性脑病中的新型 tau 丝折叠包裹疏水分子。
Nature. 2019 Apr;568(7752):420-423. doi: 10.1038/s41586-019-1026-5. Epub 2019 Mar 20.
5
Cryo-EM structure of a light chain-derived amyloid fibril from a patient with systemic AL amyloidosis.系统性轻链淀粉样变性患者来源的轻链衍生淀粉样纤维的冷冻电镜结构。
Nat Commun. 2019 Mar 20;10(1):1103. doi: 10.1038/s41467-019-09032-0.
6
Cryo-EM structure of cardiac amyloid fibrils from an immunoglobulin light chain AL amyloidosis patient.免疫球蛋白轻链 AL 淀粉样变性患者心脏淀粉样纤维的冷冻电镜结构。
Nat Commun. 2019 Mar 20;10(1):1269. doi: 10.1038/s41467-019-09133-w.
7
Cryo-EM fibril structures from systemic AA amyloidosis reveal the species complementarity of pathological amyloids.Cryo-EM 纤维结构来自系统性 AA 淀粉样变性,揭示了病理性淀粉样蛋白的物种互补性。
Nat Commun. 2019 Mar 7;10(1):1104. doi: 10.1038/s41467-019-09033-z.
8
Transthyretin: roles in the nervous system beyond thyroxine and retinol transport.甲状腺素运载蛋白:在神经系统中除甲状腺素和视黄醇转运之外的作用。
Expert Rev Endocrinol Metab. 2012 Mar;7(2):181-189. doi: 10.1586/eem.12.2.
9
Heparin-induced tau filaments are polymorphic and differ from those in Alzheimer's and Pick's diseases.肝素诱导的 tau 丝是多态的,与阿尔茨海默病和匹克病中的 tau 丝不同。
Elife. 2019 Feb 5;8:e43584. doi: 10.7554/eLife.43584.
10
The structure of a β-microglobulin fibril suggests a molecular basis for its amyloid polymorphism.β-微球蛋白纤维的结构提示了其淀粉样多态性的分子基础。
Nat Commun. 2018 Oct 30;9(1):4517. doi: 10.1038/s41467-018-06761-6.